Relapsed and Refractory Peripheral T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed and Refractory Peripheral T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05527275) | Sun Yat-sen University | 2022-10-01 |
Track Relapsed and Refractory Peripheral T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.